Cigna sees 2020 full year medical customer growth of 150,000-250,000 customers
Cigna disclosed earlier that officials expect to participate in meetings with investors and analysts on January 13 and 14, 2020 at the J.P. Morgan Healthcare Conference, including a presentation with David Cordani, Cigna's President and CEO. During these meetings, Cigna officials expect to disclose expectations for growth in 2020, including total full year medical customer growth of 150,000 to 250,000 customers over Cigna's year-end 2019 total medical customer base, including individual Medicare Advantage growth of 60,000 to 70,000 customers, representing 13% to 16% growth over year-end 2019. In addition, Cigna management also intends to disclose the company's expectations for 2020 Health Services' adjusted pharmacy scripts in the range of 1.47B to 1.50B, representing growth of 250M to 280M adjusted pharmacy scripts or 20% to 23% over year-end 2019. This outlook includes volumes expected to be insourced from OptumRx and volumes associated with the first year of the Prime Therapeutics LLC collaboration, as well as additional organic growth of 25M to 35M adjusted pharmacy scripts. Cigna's full year 2019 results will be discussed in a press release and investor conference call scheduled for February 6, the company noted.